These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 38520490)
1. Suppression of planktonic and biofilm of Escherichia coli by the synergistic lantibiotics-polymyxins combinations. Polyudova T; Lemkina L; Eroshenko D; Esaev A Arch Microbiol; 2024 Mar; 206(4):191. PubMed ID: 38520490 [TBL] [Abstract][Full Text] [Related]
2. Synergistic Antimicrobial Activity Between the Broad Spectrum Bacteriocin Garvicin KS and Nisin, Farnesol and Polymyxin B Against Gram-Positive and Gram-Negative Bacteria. Chi H; Holo H Curr Microbiol; 2018 Mar; 75(3):272-277. PubMed ID: 29058043 [TBL] [Abstract][Full Text] [Related]
4. Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii. Thomas VM; Brown RM; Ashcraft DS; Pankey GA Int J Antimicrob Agents; 2019 May; 53(5):663-668. PubMed ID: 30880230 [TBL] [Abstract][Full Text] [Related]
5. Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells. Brunati C; Thomsen TT; Gaspari E; Maffioli S; Sosio M; Jabes D; Løbner-Olesen A; Donadio S J Antimicrob Chemother; 2018 Feb; 73(2):414-424. PubMed ID: 29092042 [TBL] [Abstract][Full Text] [Related]
6. The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria. Draper LA; Cotter PD; Hill C; Ross RP BMC Microbiol; 2013 Sep; 13():212. PubMed ID: 24069959 [TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of class I and IIa bacteriocins combined with polymyxin E against resistant variants of Listeria monocytogenes and Escherichia coli. Naghmouchi K; Belguesmia Y; Baah J; Teather R; Drider D Res Microbiol; 2011; 162(2):99-107. PubMed ID: 20868743 [TBL] [Abstract][Full Text] [Related]
8. Synergistic antibacterial and anti-biofilm activities of resveratrol and polymyxin B against multidrug-resistant Pseudomonas aeruginosa. Qi L; Liang R; Duan J; Song S; Pan Y; Liu H; Zhu M; Li L J Antibiot (Tokyo); 2022 Oct; 75(10):567-575. PubMed ID: 35999263 [TBL] [Abstract][Full Text] [Related]
9. The polymyxin derivative NAB739 is synergistic with several antibiotics against polymyxin-resistant strains of Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii. Tyrrell JM; Aboklaish AF; Walsh TR; Vaara T; Vaara M Peptides; 2019 Feb; 112():149-153. PubMed ID: 30586602 [TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of ovine-derived cathelicidins and other antimicrobials against Escherichia coli O157:H7 and Staphylococcus aureus 1056 MRSA. van der Linden DS; Short D; Dittmann A; Yu PL Biotechnol Lett; 2009 Aug; 31(8):1265-7. PubMed ID: 19396584 [TBL] [Abstract][Full Text] [Related]
11. MCR-1 Inhibition with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Sensitivity to Polymyxin in Daly SM; Sturge CR; Felder-Scott CF; Geller BL; Greenberg DE mBio; 2017 Nov; 8(6):. PubMed ID: 29114023 [TBL] [Abstract][Full Text] [Related]
12. Susceptibility of gram-negative bacteria to polymyxin B nonapeptide. Viljanen P; Vaara M Antimicrob Agents Chemother; 1984 Jun; 25(6):701-5. PubMed ID: 6331296 [TBL] [Abstract][Full Text] [Related]
13. Effects of Colistin and Bacteriocins Combinations on the In Vitro Growth of Escherichia coli Strains from Swine Origin. Al Atya AK; Abriouel H; Kempf I; Jouy E; Auclair E; Vachée A; Drider D Probiotics Antimicrob Proteins; 2016 Dec; 8(4):183-190. PubMed ID: 27557837 [TBL] [Abstract][Full Text] [Related]
14. Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy? Ardebili A; Izanloo A; Rastegar M Expert Rev Anti Infect Ther; 2023 Apr; 21(4):387-429. PubMed ID: 36820511 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of the ATP Synthase Eliminates the Intrinsic Resistance of Vestergaard M; Nøhr-Meldgaard K; Bojer MS; Krogsgård Nielsen C; Meyer RL; Slavetinsky C; Peschel A; Ingmer H mBio; 2017 Sep; 8(5):. PubMed ID: 28874470 [No Abstract] [Full Text] [Related]
17. Evaluation of the interaction between polymyxin B and Pseudomonas aeruginosa biofilm and planktonic cells: reactive oxygen species induction and zeta potential. Lima MR; Ferreira GF; Nunes Neto WR; Monteiro JM; Santos ÁRC; Tavares PB; Denadai ÂML; Bomfim MRQ; Dos Santos VL; Marques SG; de Souza Monteiro A BMC Microbiol; 2019 May; 19(1):115. PubMed ID: 31142260 [TBL] [Abstract][Full Text] [Related]
18. Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City. Quale J; Shah N; Kelly P; Babu E; Backer M; Rosas-Garcia G; Salamera J; George A; Bratu S; Landman D Microb Drug Resist; 2012 Apr; 18(2):132-6. PubMed ID: 22196342 [TBL] [Abstract][Full Text] [Related]
19. Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens. Li Q; Montalban-Lopez M; Kuipers OP Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29625984 [TBL] [Abstract][Full Text] [Related]
20. Nitazoxanide synergizes polymyxin B against Jiang X; Chen D; Wang X; Wang C; Zheng H; Ye W; Zhou W; Liu G; Zhang K Microbiol Spectr; 2024 Aug; 12(8):e0019124. PubMed ID: 38904380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]